Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-072619
Filing Date
2025-05-15
Accepted
2025-05-15 16:09:53
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sepn-20250331.htm   iXBRL 10-Q 1912838
2 EX-31.1 sepn-ex31_1.htm EX-31.1 17994
3 EX-31.2 sepn-ex31_2.htm EX-31.2 17768
4 EX-32.1 sepn-ex32_1.htm EX-32.1 16723
5 GRAPHIC img118497663_0.jpg GRAPHIC 96625
  Complete submission text file 0000950170-25-072619.txt   8807190

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sepn-20250331.xsd EX-101.SCH 1179730
65 EXTRACTED XBRL INSTANCE DOCUMENT sepn-20250331_htm.xml XML 1705945
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42382 | Film No.: 25952998
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)